Sat. Apr 18th, 2026

Breakthrough £90,000 Alzheimer's drugs unlikely to benefit patients, report suggests



A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.

Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *